共 158 条
[1]
Silverman DT(1999)Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer Br J Cancer 80 1830-1837
[2]
Schiffman M(2005)Treatment for pancreatic cancer: current therapy and continued progress Gastroenterology 128 1642-1654
[3]
Everhart J(1999)Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database J Am Coll Surg 189 1-7
[4]
Goldstein A(1997)Recurrence after resection for ductal adenocarcinoma of the pancreas World J Surg 21 195-200
[5]
Lillemoe KD(1990)Patterns of failure after curative resection of pancreatic carcinoma Cancer 66 56-61
[6]
Swanson GM(1993)Recurrence of exocrine pancreatic cancer—local or hepatic? Hepatogastroenterology 40 384-387
[7]
Lockhart AC(1994)A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil Eur J Cancer 30A 1517-1522
[8]
Rothenberg ML(2004)Evaluation of sensitivity to 5-FU on the basis of thymidylate synthase (TS)/dihydropyrimidine dehydrogenase (DPD) activity and chromosomal analysis in micro tissue specimens of breast cancer Breast Cancer (Tokyo, Japan) 11 356-366
[9]
Berlin JD(2004)Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer Br J Cancer 91 1245-1250
[10]
Sener SF(2007)DPD is a molecular determinant of capecitabine efficacy in colorectal cancer Int J Oncol 31 413-418